Participants in the UAE's COVID-19 vaccine programme will not have to quarantine for 14 days on returning to Abu Dhabi from abroad following a new ruling.
The Abu Dhabi Emergency, Crisis and Disasters Committee for COVID-19 Pandemic has approved the measures specifically for participants in the Phase III clinical trials of the vaccine or the National Vaccination Programme for emergency use.
It will apply to participants in the vaccine trial immediately after their first dose, while participants in the National Vaccination Programme can do so 28 days after their second dose.
Authorities added that PCR tests will be mandatory for all vaccine participants before travelling and upon returning to the Emirate.
Trial participants, who are identified by a gold star in the Alhosn app, will be exempt from PCR tests on the 4th and 8th day after entry into the Emirate.
Participants identified by the letter E in the Alhosn app will have to take the PCR tests on the 4th and 8th day after entry.
Meanwhile, all trial participants will not be required to a PCR or DPI test to enter Abu Dhabi from within the UAE.
The special measures are only valid if the participant’s Alhosn app continues to show their special status, which is linked to taking a PCR test every fortnight, as per the conditions of the trial and vaccination programme.
The Abu Dhabi Emergency, Crisis and Disasters Committee for Covid-19 Pandemic has approved special measures for participants in the Phase III clinical trials of the vaccine or the National Vaccination Programme. pic.twitter.com/7gkljya4CZ
— مكتب أبوظبي الإعلامي (@ADMediaOffice) November 25, 2020
Abu Dhabi identifies over 40 modern heritage sites
Distribution of aid from UAE's Saqr Humanitarian Ship begins in Gaza
Dubai to expand bus and taxi lanes as public transport ridership grows by 7.4%
Emir of Qatar welcomed by UAE President on visit to Abu Dhabi
UAE, Egypt Foreign Ministers discuss Gaza peace plan
